BUY Concord Biotech LimitedIDBI Capital

byIDBI CapitalHorizon: NA (inferred 1–3 months)21 Sept 2026via IDBI Capital Research Calls Telegram

Entry₹1,546Stated
Target₹1,685
Stop loss₹1,475-4.59% risk
CMP₹1,532.45h ago
Active-0.88%+9.96%upside left 3 mo left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Sept, 9:37 pm IST
5 supporting0 opposing
Supports the BUY call (5)

MACD above its signal line — bullish momentum

Technicals · macd·22 Sept · today

Concord Biotech bonus issue sparks rally! Pharma stock jumps 6% on maiden share reward - Top things to know

NewsLivemint·21 Sept · yesterday

(opens in new tab)

Bonus Alert: Stock with significant Jhunjhunwala family stake set to reward shareholders

NewsCnbc-Tv18·21 Sept · yesterday

(opens in new tab)

2 advisors have active long-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·21 Sept · yesterday

1 other SEBI-registered advisor has an active short-term BUY call on this stock

Advisor consensus · same horizon·30 Jul · 2mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.